DRUG
Bright Minds·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
DRUG Filings
Filing Date
Form Description
Form Type
2025-11-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-17
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2025-11-17 ·
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-03
Form EFFECT - Notice of Effectiveness
2025-09-03 ·
Form EFFECT - Notice of Effectiveness
2025-08-28
Form CORRESP - Correspondence
SEC Inquiries
2025-08-28 · SEC Inquiries
Form CORRESP - Correspondence
